`
`
`
`
`CENTER FOR DRUG EVALUATION AND
`RESEARCH
`
`
`
`APPLICATION NUMBER:
`
`210563Orig1s000
`
`OFFICER/EMPLOYEE LIST
`
`
`
`List of Officers/Employees
`NDA 210563 Imbruvica® (ibrutinib)
`
`The following FDA employees have been identlfied as having participated in the review and approval decision
`for this application, NDA 210563, and they have consented to have their name appear on the list ofemployees.
`
`Anand, Om
`
`Baird, Amy
`
`Banerjee, Anamitro
`
`De Claro, R. Angelo
`
`Dorantes, Angelica
`
`Eradiri, Okpo
`
`Farrel], Ann T.
`
`Fuller, Barbara
`
`Haider, Rabiya
`
`Kwitkowski, Virginia
`
`Leaman, Diane
`
`Leong, Ruby
`
`Li, Liang '
`
`Majumder, Quamrul
`
`McLamorc-Hincs, Sherita
`
`' Mehta, Hina
`
`Miller, Kelly
`
`Miller, Mara Bauman
`
`Moore, Ruth~
`
`Okusanya, Olanrcwaju
`
`Patel, Nisha
`
`Redwood, Susan
`
`Ryan, Qin
`Sheth, Christopher
`
`Sn, Ziyang
`Vara, Neil
`
`Wang, Xing
`
`